Takeda Pharmaceutical
TAK
#457
Rank
C$78.13 B
Marketcap
C$24.47
Share price
1.38%
Change (1 day)
19.92%
Change (1 year)

Earnings for Takeda Pharmaceutical (TAK)

Earnings in 2026 (TTM): C$0.29 Billion

According to Takeda Pharmaceutical's latest financial reports the company's current earnings are C$29.73 Billion. In 2025 the company made an earning of C$4.61 Billion, an increase over its 2024 earnings that were of C$3.09 Billion. The earnings displayed on this page is the company's Pretax Income.

Earnings history for Takeda Pharmaceutical from 2009 to 2026

Annual earnings

Year Earnings Change
2026 (TTM) C$0.29 B-93.55%
2025 C$4.61 B49.03%
2024 C$3.09 B-2.41%
2023 C$3.17 B-28.14%
2022 C$4.41 B-40.9%
2021 C$7.47 B78.24%
2020 C$4.19 B246.1%
2019 C$1.21 B-48.79%
2018 C$2.36 B-23.64%
2017 C$3.09 B21.7%
2016 C$2.54 B-253.01%
2015 -C$1.67 Billion-159.65%
2014 C$2.78 B13%
2013 C$2.46 B2.46%
2012 C$2.40 B-57.05%
2011 C$5.60 B-10.49%
2010 C$6.26 B-3.99%
2009 C$6.52 B

Earnings for similar companies or competitors

Company Earnings Earnings differencediff. Country
Johnson & Johnson
JNJ
C$36.05 B 9,308.59%๐Ÿ‡บ๐Ÿ‡ธ USA
Novartis
NVS
C$21.90 B 5,616.36%๐Ÿ‡จ๐Ÿ‡ญ Switzerland
Pfizer
PFE
C$14.69 B 3,735.65%๐Ÿ‡บ๐Ÿ‡ธ USA
Amgen
AMGN
C$12.61 B 3,190.96%๐Ÿ‡บ๐Ÿ‡ธ USA
Sanofi
SNY
C$10.62 B 2,673.61%๐Ÿ‡ซ๐Ÿ‡ท France
Merck
MRK
C$18.25 B 4,663.15%๐Ÿ‡บ๐Ÿ‡ธ USA
GSK plc
GSK
C$13.89 B 3,525.74%๐Ÿ‡ฌ๐Ÿ‡ง UK
Seagen
SGEN
-C$1.1 Billion-386.32%๐Ÿ‡บ๐Ÿ‡ธ USA
Dr. Reddy's Laboratories
RDY
C$0.92 B 140.37%๐Ÿ‡ฎ๐Ÿ‡ณ India